IGF1(CA)19 and IGFBP-3-202A/C Gene Polymorphism and Cancer Risk: A Meta-analysis

Cell Biochemistry and Biophysics

Volumn 69, Issue 1, 2014, Pages 169-178

  Quan, Hongyu ^a   Tang, Hao ^a   Fang, Li ^b   Bi, Jianjun ^b   Liu, Yunsheng ^a   Li, Hongli ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The 169th Hospital of PLA   (China)

Author keywords

Cancer; Gene polymorphism; IGF1(CA)19; IGFBP 3 202A C; Meta analysis

Indexed keywords

IGF1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; BREAST NEOPLASMS; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; META ANALYSIS; PROSTATIC NEOPLASMS; RISK FACTOR;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MODELS, GENETIC; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84899449029     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9784-4     Document Type: Article

References (39)

1. Werner, H., & LeRoith, D. (1996). The role of the insulin-like growth factor system in human cancer. Advances in Cancer Research, 68, 183-223.
2. Hellawell, G. O., Turner, G. D., Davies, D. R., Poulsom, R., Brewster, S. F., & Macaulay, V. M. (2002). Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Research, 62(10), 2942-2950.
3. Firth, S. M., & Baxter, R. C. (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocrine Reviews, 23(6), 824-854.
4. Bruning, P. F., van Doorn, J., Bonfrer, J. M., van Noord, P. A., Korse, C. M., Linders, T. C., et al. (1995). Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. International Journal of Cancer, 62(3), 266-270.
5. Neumuller, R. A., & Knoblich, J. A. (2009). Dividing cellular asymmetry: Asymmetric cell division and its implications for stem cells and cancer. Genes & Development, 23(23), 2675-2699. doi: 10. 1101/gad. 1850809.
6. Rietveld, I., Janssen, J. A., van Duijn, C. M., & Lamberts, S. W. (2003). A polymorphic CA repeat in the promoter region of the insulin-like growth factor-I (IGF-I) gene. European Journal of Epidemiology, 18(3), 191-193.
7. Rosendahl, A. H., Hietala, M., Henningson, M., Olsson, H., & Jernstrom, H. (2011). IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Breast Cancer Research and Treatment, 127(3), 785-794. doi: 10. 1007/s10549-010-1277-1.
8. Schernhammer, E. S., Hankinson, S. E., Hunter, D. J., Blouin, M. J., & Pollak, M. N. (2003). Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. International Journal of Cancer, 107(1), 60-64. doi: 10. 1002/ijc. 11358.
9. Costalonga, E. F., Antonini, S. R., Guerra-Junior, G., Mendonca, B. B., Arnhold, I. J., & Jorge, A. A. (2009). The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 94(2), 588-595. doi: 10. 1210/jc. 2008-1608.
10. Pechlivanis, S., Wagner, K., Chang-Claude, J., Hoffmeister, M., Brenner, H., & Forsti, A. (2007). Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Cancer Detection and Prevention, 31(5), 408-416. doi: 10. 1016/j. cdp. 2007. 10. 001.
11. Samowitz, W. S., Wolff, R. K., Ma, K. N., Andersen, K., Caan, B., & Slattery, M. L. (2006). Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Mutation Research, 595(1-2), 117-124. doi: 10. 1016/j. mrfmmm. 2005. 10. 014.
12. Wong, H. L., Delellis, K., Probst-Hensch, N., Koh, W. P., van Den Berg, D., Lee, H. P., et al. (2005). A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiology, Biomarkers & Prevention, 14(1), 144-151. doi: 14/1/144.
13. Slattery, M. L., Murtaugh, M., Caan, B., Ma, K. N., Neuhausen, S., & Samowitz, W. (2005). Energy balance, insulin-related genes and risk of colon and rectal cancer. International Journal of Cancer, 115(1), 148-154. doi: 10. 1002/ijc. 20843.
14. Morimoto, L. M., Newcomb, P. A., White, E., Bigler, J., & Potter, J. D. (2005). Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention, 14(5), 1204-1211. doi: 10. 1158/1055-9965. EPI-04-0695.
15. Sarkissyan, M., Mishra, D. K., Wu, Y., Shang, X., Sarkissyan, S., & Vadgama, J. V. (2011). IGF gene polymorphisms and breast cancer in African-American and Hispanic women. International Journal of Oncology, 38(6), 1663-1673. doi: 10. 3892/ijo. 2011. 990.
16. Slattery, M. L., Sweeney, C., Wolff, R., Herrick, J., Baumgartner, K., Giuliano, A., et al. (2007). Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Research and Treatment, 104(2), 197-209. doi: 10. 1007/s10549-006-9403-9.
17. Gonzalez-Zuloeta Ladd, A. M., Liu, F., Houben, M. P., Arias Vasquez, A., Siemes, C., Janssens, A. C., et al. (2007). IGF-1 CA repeat variant and breast cancer risk in postmenopausal women. European Journal of Cancer, 43(11), 1718-1722. doi: 10. 1016/j. ejca. 2007. 04. 026.
18. Cleveland, R. J., Gammon, M. D., Edmiston, S. N., Teitelbaum, S. L., Britton, J. A., Terry, M. B., et al. (2006). IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis, 27(4), 758-765. doi: 10. 1093/carcin/bgi294.
19. Wen, W., Gao, Y. T., Shu, X. O., Yu, H., Cai, Q., Smith, J. R., et al. (2005). Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. International Journal of Cancer, 113(2), 307-311. doi: 10. 1002/ijc. 20571.
20. Wagner, K., Hemminki, K., Israelsson, E., Grzybowska, E., Soderberg, M., Pamula, J., et al. (2005). Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Research and Treatment, 92(2), 133-140. doi: 10. 1007/s10549-005-2417-x.
21. DeLellis, K., Ingles, S., Kolonel, L., McKean-Cowdin, R., Henderson, B., Stanczyk, F., et al. (2003). IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. British Journal of Cancer, 88(2), 277-282. doi: 10. 1038/sj. bjc. 6600728.
22. Hernandez, W., Grenade, C., Santos, E. R., Bonilla, C., Ahaghotu, C., & Kittles, R. A. (2007). IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis, 28(10), 2154-2159. doi: 10. 1093/carcin/bgm190.
23. Chen, C., Freeman, R., Voigt, L. F., Fitzpatrick, A., Plymate, S. R., & Weiss, N. S. (2006). Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor. Cancer Epidemiology, Biomarkers & Prevention, 15(12), 2461-2466. doi: 10. 1158/1055-9965. EPI-06-0541.
24. Neuhausen, S. L., Slattery, M. L., Garner, C. P., Ding, Y. C., Hoffman, M., & Brothman, A. R. (2005). Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: Strong association of IRS1 G972R variant and cancer risk. Prostate, 64(2), 168-174. doi: 10. 1002/pros. 20216.
25. Friedrichsen, D. M., Hawley, S., Shu, J., Humphrey, M., Sabacan, L., Iwasaki, L., et al. (2005). IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Prostate, 65(1), 44-51. doi: 10. 1002/pros. 20259.
26. Schildkraut, J. M., Demark-Wahnefried, W., Wenham, R. M., Grubber, J., Jeffreys, A. S., Grambow, S. C., et al. (2005). IGF1(CA)19 repeat and IGFBP-3-202 A/C genotypes and the risk of prostate cancer in Black and White men. Cancer Epidemiol Biomarkers Prev, 14(2), 403-408. doi: 10. 1158/1055-9965. EPI-04-0426.
27. Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., et al. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283(15), 2008-2012. doi: jst00003.
28. Lau, J., Ioannidis, J. P., & Schmid, C. H. (1997). Quantitative synthesis in systematic reviews. Annals of Internal Medicine, 127(9), 820-826.
29. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177-188. doi: 0197-2456(86)90046-2.
30. Mantel, N., & Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute, 22(4), 719-748.
31. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629-634.
32. Reeves, S. G., Rich, D., Meldrum, C. J., Colyvas, K., Kurzawski, G., Suchy, J., et al. (2008). IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer. International Journal of Cancer, 123(6), 1339-1343. doi: 10. 1002/ijc. 23668.
33. Li, L., Cicek, M. S., Casey, G., & Witte, J. S. (2004). No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiology, Biomarkers & Prevention, 13(3), 497-498.
34. Giovannucci, E., Haiman, C. A., Platz, E. A., Hankinson, S. E., Pollak, M. N., & Hunter, D. J. (2002). Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenoma. Cancer Epidemiology, Biomarkers & Prevention, 11(11), 1509-1510.
35. Missmer, S. A., Haiman, C. A., Hunter, D. J., Willett, W. C., Colditz, G. A., Speizer, F. E., et al. (2002). A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. International Journal of Cancer, 100(3), 332-336. doi: 10. 1002/ijc. 10473.
36. Figer, A., Karasik, Y. P., Baruch, R. G., Chetrit, A., Papa, M. Z., Sade, R. B., et al. (2002). Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. The Israel Medical Association Journal: IMAJ, 4(10), 759-762.
37. Yu, H., Li, B. D., Smith, M., Shi, R., Berkel, H. J., & Kato, I. (2001). Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Research and Treatment, 70(2), 117-122.
38. Engeland, A., Tretli, S., & Bjorge, T. (2003). Height, body mass index, and prostate cancer: A follow-up of 950000 Norwegian men. British Journal of Cancer, 89(7), 1237-1242. doi: 10. 1038/sj. bjc. 6601206.
39. Chen, X., Guan, J., Song, Y., Chen, P., Zheng, H., Tang, C., et al. (2008). IGF-I (CA) repeat polymorphisms and risk of cancer: A meta-analysis. Journal of Human Genetics, 53(3), 227-238. doi: 10. 1007/s10038-007-0241-3.